Targeting Intestinal Epithelium to Promote Healing in Inflammatory Bowel Disease
Targeting Intestinal Epithelium to Promote Healing in Inflammatory Bowel Disease
批准号:
9517035
负责人:
James Bayrer
金额:
$16.94万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-18 至 2019-06-30
关键词:
AddressAdultAdvisory CommitteesAffectAnimal GeneticsAnimal ModelAnimalsAnti-inflammatoryApoptosisBackBasic ScienceBindingBiologyCellsChIP-seqChildChildhoodChronicChronic DiseaseClinicalClinical SciencesColitisComplementCoupledCuesDataData AnalysesDependovirusDevelopmentDiagnosisDimensionsDiseaseDisease modelDissectionDrug DesignDrug TargetingEducational workshopEngineeringEnvironmentEpithelialEpithelial CellsExperimental ModelsFosteringFunctional disorderFutureGastroenterologistGastroenterologyGastrointestinal tract structureGene ExpressionGene TargetingGenesGenetic ModelsGenetic TranscriptionGoalsGrantGrowthHeadHealth Care CostsHollyHomeostasisHumanImmuneImmunologyImpairmentIndividualInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInflammatory disease of the intestineInjuryIntestinal DiseasesIntestinesKnock-outKnockout MiceLaboratoriesLeadLigand BindingLigandsLoxP-flanked alleleManuscriptsMediatingMentorsMetabolicModelingMolecularMorbidity - disease rateMucous MembraneMusMutationNR5A2 geneNatural regenerationNuclear ReceptorsOrganoidsPathway interactionsPatientsPharmacologyPhysiciansPredispositionProductionRecording of previous eventsResearchResearch PersonnelResearch TrainingResistanceReview CommitteeRoleScienceScientistSpeedStem cellsSteroidsSuggestionSulfonic AcidsSystemTechniquesTestingTherapeuticTight JunctionsTrainingTranscriptTranslational ResearchTrinitrobenzenesWorkWritingbasecareercareer developmentcell growthdesigndrug developmentgenetic manipulationhealinghumanized mouseimmune functionin vivoin vivo Modelinflammatory markerinterestintestinal cryptintestinal epitheliumlight microscopymouse modelmutantnew therapeutic targetnovelnovel therapeuticsoverexpressionpediatric departmentprogramsreceptorresponseresponse to injuryresponsible research conductself-renewalskillssuccesstissue culturetranscriptome sequencingtranslational research programvillin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Approach:
I will focus on the NR5A nuclear receptor Liver Receptor Homolog-1 (LRH-1, NR5A2), increasingly recognized
for its roles in cell growth and its anti-inflammatory transcription profile. Mice lacking intestinal LRH-1 knockout
show increased mucosal damage and inflammatory markers in IBD models. I hypothesize that loss of LRH-1
will impair epithelial renewal and response to injury, and that enhanced LRH-1 expression will dampen
intestinal inflammation and speed mucosal healing. I have developed an ex vivo intestinal organoid culture
(enteroid) system to study epithelial responses to injury. The enteroid system allows me to directly address the
role of LRH-1 in intestinal epithelial pathophysiology by using conditional mouse genetic models that eliminates
LRH-1 in the intestinal epithelium (Villin-CreER). I have adapted the adeno-associated virus (AAV) system to
enable expression of human LRH-1 and important LRH-1 mutations in the enteroid system to further probe
LRH-1-mediated epithelial function. I will use in vivo IBD models with both conditional LRH-1 knockout and
overexpression to build upon my ex vivo studies, and to define the role of LRH-1 in epithelial injury and
inflammatory response. My work will determine if LRH-1 activation is sufficient to blunt immune-mediated
mucosal injury and ask if LRH-1 can be targeted for IBD drug development. I believe that the questions being
asked and the experimental models outlined in this Mentored-based K08 application are exciting and highly
relevant to my clinical interests in inflammatory intestinal disorders.
Candidate & Rationale:
I am a dual-degree physician scientist MSTP graduate trained in gastroenterology and pharmacology. In this
proposal I seek to understand the molecular pathways that govern bowel homeostasis and the adaptive
mechanisms that drive injury response. In the intestine, inflammatory responses are mediated by both
metabolic and environmental cues. Inflammatory bowel disease (IBD) is a chronic disease that affects both
adults and children alike, imposing significant morbidity and healthcare costs. Understanding how the
intestinal epithelium self-renews and maintains its integrity in the face of inflammatory damage is key to the
development of novel therapies for intestinal disease. My ultimate goal is to head an independent research
program focused on translational intestinal disease models and therapeutic design.
Career goals:
Through the framework delineated by this proposal, I will establish an independent research program
dedicated to understanding intestinal pathophysiology and the development of novel therapeutics. The
research plan described herein is designed to expand my expertise into new arenas of animal genetics and
disease modeling. This is consistent with my long-term goals of translational science, bringing discoveries from
my laboratory back to benefit my patients. The mentoring I will receive by my Advisory Committee coupled with
the career development workshops at UCSF such as grant and manuscript writing, will foster both my
professional and scientific development.
Environment:
I have identified a strong mentoring team lead by Dr. Holly Ingraham, a leader in nuclear receptor biology. Dr.
Averil Ma, an expert in IBD and animal models of colitis, and Dr. Ophir Klein, a physician scientist with
epithelial stem cell expertise, round out my Advisory Committee with complementary skill sets. To enhance my
research training, I will engage in didactic coursework in immunology, advanced light microscopy, high
throughput data analysis, and the responsible conduct of research. UCSF provides a stimulating environment
for the pursuit of science with a highly collaborative network of investigators. The Department of Pediatrics and
the Division of Gastroenterology each have a long history of developing future leaders in basic and clinical
science.
In summary, as a highly motivated clinician scientist, my ultimate goal is to develop an independent basic and
translational research program focused on intestinal disorders. This proposal provides necessary training in
research coupled with a strong mentoring plan to help me achieve success.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Decoding LRH-1 Activity in Gut Regeneration and Differentiation
-
批准号:10427197
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2021
-
负责人:James Bayrer
-
依托单位:
Decoding LRH-1 Activity in Gut Regeneration and Differentiation
-
批准号:10726639
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2021
-
负责人:James Bayrer
-
依托单位:
Resubmission of Diversity Supplement
-
批准号:10579764
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2021
-
负责人:James Bayrer
-
依托单位:
Decoding LRH-1 Activity in Gut Regeneration and Differentiation
-
批准号:10184708
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2021
-
负责人:James Bayrer
-
依托单位:
Decoding LRH-1 Activity in Gut Regeneration and Differentiation
-
批准号:10613992
-
项目类别:
-
资助金额:$52.53万
-
财政年份:2021
-
负责人:James Bayrer
-
依托单位:
Uncovering the role of LRH-1 in enteroendocrine cell development and ‘gut-brain’ communication
-
批准号:9920708
-
项目类别:
-
资助金额:$12.09万
-
财政年份:2019
-
负责人:James Bayrer
-
依托单位:
Targeting Intestinal Epithelium to Promote Healing in Inflammatory Bowel Disease
-
批准号:9180524
-
项目类别:
-
资助金额:$15.86万
-
财政年份:2016
-
负责人:James Bayrer
-
依托单位:
LRH-1: Structure-based Approach to Drug Design for Gastrointestinal Tumors
-
批准号:8314808
-
项目类别:
-
资助金额:$5.94万
-
财政年份:2012
-
负责人:James Bayrer
-
依托单位:
LRH-1: Structure-based Approach to Drug Design for Gastrointestinal Tumors
-
批准号:8460183
-
项目类别:
-
资助金额:$1.75万
-
财政年份:2012
-
负责人:James Bayrer
-
依托单位:
海外基金